Juxtapid Capsule
Product Images NDC 76431-110

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Juxtapid (NDC 76431-110). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amryt Pharmaceuticals Dac, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Juxtapid 01)

Chemical structure of the active ingredient in Juxtapid, illustrating the molecular arrangement including multiple aromatic rings, trifluoromethyl groups (CF3), and a methylsulfonic acid (CH3SO3H) moiety.*

FDA Label Image

Figure 1 (Juxtapid 02)

A line graph showing the mean percentage change in direct LDL-C from baseline over a period of 26 weeks. The x-axis represents weeks, with corresponding mean doses indicated above the axis ranging from 5 mg to 45 mg. The y-axis shows mean percentage change in LDL-C from 0 to -70%. Data points include week 26 completers and week 26 last observation carried forward (LOCF) with error bars indicating variability.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Label)

Juxtapid 5 mg capsules label showing the active ingredient lomitapide at 5 mg strength, with a quantity of 28 capsules in the package. The label includes storage instructions (20°C to 25°C), manufacturer information (Amryt Pharmaceuticals DAC, Dublin, Ireland), and notes that the product is Rx only with dosage instructions to see the package insert.*

FDA Label Image

Principal Display Panel (5 mg Capsule Bottle Carton)

Juxtapid 5 mg capsules packaging label for a 28-capsule carton by Amryt Pharmaceuticals DAC. The label lists lomitapide as the active ingredient with storage instructions and a note for pharmacists to dispense the Medication Guide. The design features the Juxtapid logo and dosage strength on a white background with yellow accent bands.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Label)

Juxtapid 10 mg capsules packaging label shows the product name with the active ingredient lomitapide. The label states that each capsule contains 10 mg lomitapide and displays the quantity of 28 capsules. It includes storage instructions and indicates the labeler as Amryt Pharmaceuticals DAC, Dublin, Ireland.*

FDA Label Image

Principal Display Panel (10 mg Capsule Bottle Carton)

Juxtapid 10 mg capsules packaging label for 28 capsules by Amryt Pharmaceuticals DAC. The label shows the proprietary name Juxtapid with the active ingredient lomitapide. It includes storage instructions and pharmacist dispensing guidance. The label design features the Amryt Pharma logo and dosage strength in an orange band.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Label)

Juxtapid 20 mg capsules packaging label showing 28 capsules per package. The label specifies each capsule contains 20 mg lomitapide, manufactured for Amryt Pharmaceuticals DAC. Storage instructions, caution to keep out of reach of children, and a barcode are also visible. The label includes an Rx only notice with dosage and use instructions to see package insert.*

FDA Label Image

Principal Display Panel (20 mg Capsule Bottle Carton)

Juxtapid 20 mg capsules carton label showing the brand name and active ingredient lomitapide. The label indicates a package size of 28 capsules and includes storage instructions and a reminder to dispense the medication guide. The labeler is Amryt Pharmaceuticals DAC, Dublin, Ireland. Barcode and glue tabs are visible for carton assembly.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Label)

Juxtapid 30 mg capsules label showing the active ingredient lomitapide. It displays a quantity of 28 capsules and mentions Amryt Pharmaceuticals DAC as the manufacturer. The label includes storage instructions and a barcode with NDC 76431-130-01, indicating it is prescription-only.*

FDA Label Image

Principal Display Panel (30 mg Capsule Bottle Carton)

Inner packaging label for Juxtapid 30 mg capsules by Amryt Pharmaceuticals DAC. The label indicates the active ingredient lomitapide in each 30 mg capsule, with storage instructions and dispensing information. The label also includes barcodes and manufacturer details in Dublin, Ireland.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.